These results suggest that oncogenic activation of C-MYC could be mediated by the regulation of the Wnt/β-catenin signaling pathway, which is also activated in GBM, promoting proliferation processes, apoptosis inhibition, and cell invasion [85]. The gene discussed is MYC; the disease is glioblastoma.